Delivery Order HHSA290201200009I-HHSA29032001T

The Defense Health Agency awarded a $23,697.13 firm fixed-price call order to Harvard Bioscience Inc. (operating as Data Sciences International) on December 5, 2024, for medical research implants, with performance scheduled to conclude by September 30, 2025. This contract call is issued under Harvard Bioscience's existing $4.8 million single-award Blanket Purchase Agreement with the Defense Health Agency, which was established on May 4, 2022, and remains active through May 3, 2027. The BPA...

Rivanna Medical, Inc. has been awarded a $91.5 million cost-plus-fixed-fee definitive contract by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the Department of Health and Human Services to develop, refine, and manufacture the Accuro XV, a handheld ultrasound device designed for rapid, radiation-free fracture triage in mass casualty blast trauma incidents. The contract, which is not set-aside and has an ultimate completion date of September 29, 2029,...

The University of Pennsylvania was awarded an $8.69 million cost-no-fee definitive contract by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to advance the development of inhalation toxicology research for chlorine gas exposure using organ-on-chip platform technology. This research initiative supports the accelerated and cost-effective development of medical countermeasures and biomarkers for treating chlorine gas-induced lung injury, aligned with BARDA's (Biomedical...

This delivery order task (H-126361) was awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., by the National Cancer Institute on September 27, 2023, for the Wedgewood Suite M & N Expansion modification project in Frederick, Maryland. The contract carries a ceiling value of $16.4 million and extends through June 18, 2026, utilizing a cost-plus-fixed-fee pricing structure with no set-aside designation. Leidos Biomedical Research Inc. operates as a Federally Funded...

Leidos, Inc. was awarded a non-severable delivery order valued at $18.4 million under the BEAR RSS contract through the Bureau of Medicine and Surgery (BUMED), a defense agency component, with an ultimate completion date of June 30, 2026. The delivery order, issued on September 11, 2020, operates under a cost-plus-fixed-fee pricing structure without a set-aside designation, reflecting Leidos' status as a large business prime contractor. Work is to be performed at the San Diego, California...

Leidos, Inc. (operating as SAIC through its Leidos Services Operating Segment) was awarded a delivery order valued at $14.8 million on June 14, 2025, to provide Research Information Technology Capabilities (RIC) Support Services to the Defense Health Agency (DHA), with performance through February 13, 2028. This firm fixed-price delivery order is issued under the Omnibus IV Military Medical Research and Development (OMNIBUS IV) master IDIQ contract vehicle and will be performed in Frederick,...

Emory University was awarded contract 75N93021C00017 on April 1, 2021 by the National Institute of Allergy and Infectious Diseases (NIAID) to establish and operate a Center of Excellence for Influenza Research and Response (CEIRR). The five-year contract, valued at $79.3 million through its September 2028 completion date, operates on a cost reimbursable basis with no fee. The award supports NIAID's initiative to create a multi-disciplinary collaborative network focused on advancing understanding...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a definitive cost-no-fee contract valued at $91.8 million to the University of Georgia Research Foundation (UGA CEIRR) on April 1, 2021, with an ultimate completion date of March 24, 2028. This award establishes one of up to seven Centers of Excellence for Influenza Research and Response (CEIRR) under NIAID's multi-disciplinary collaborative network initiative. The contract supports integrated basic and clinical...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a cost-plus-fixed-fee delivery order valued at $139.9 million to Leidos Biomedical Research Inc. on August 31, 2025, with an ultimate completion date of August 30, 2027. This NIAID Fiscal Years 2026-27 Operational Task Order, performed at the contractor's Frederick, Maryland facility, represents a continuation of Leidos Biomedical Research Inc.'s role as a Federally Funded Research and Development Center (FFRDC) supporting...

The Defense Health Agency awarded a $49.0M definitive cost-plus-fixed-fee contract to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. on August 29, 2021, to provide non-personal support services for infectious disease surveillance across Kenya, Uganda, Tanzania, and sub-Saharan Africa. The work directly supports the Walter Reed Army Institute of Research (WRAIR) Medical Research Detachment in Africa, which operates under the Department of Defense's Global...